{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:02:17Z","timestamp":1790758937978,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.eururo.2018.01.042","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T17:36:59Z","timestamp":1518889019000},"page":"474-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9024-863X","authenticated-orcid":false,"given":"Annelies","family":"Verbiest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Couchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Job","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Caruana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Lerut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Oyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"de Reyni\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Tosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Joniau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Van Poppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Van Raemdonck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Van Den Eynde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Zucman-Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Beuselinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2018.01.042_bib0170","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2018.01.042_bib0175","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.eururo.2017.11.016","article-title":"Updated European Association of Urology Guidelines Recommendations for the treatment of first-line metastatic clear cell renal cancer","volume":"73","author":"Powles","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.01.042_bib0180","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","article-title":"EAU guidelines on renal cell carcinoma: 2014 update","volume":"67","author":"Ljungberg","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.01.042_bib0185","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/MOU.0000000000000330","article-title":"Metastasis therapies for renal cancer","volume":"26","author":"Dabestani","year":"2016","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2018.01.042_bib0190","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2018.01.042_bib0195","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1016\/S1470-2045(14)70235-9","article-title":"Local treatments for metastases of renal cell carcinoma: a systematic review","volume":"15","author":"Dabestani","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2018.01.042_bib0200","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/1947601909359929","article-title":"Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns","volume":"1","author":"Brannon","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.eururo.2018.01.042_bib0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Cancer Genome Atlas Research N","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2018.01.042_bib0210","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1158\/1078-0432.CCR-14-1128","article-title":"Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting","volume":"21","author":"Beuselinck","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2018.01.042_bib0215","doi-asserted-by":"crossref","unstructured":"Verbiest A, Couchy G, Job S, et al. Molecular subtypes of clear cell renal cell carcinoma are associated with outcome during pazopanib therapy in the metastatic setting. Clin Genitourin Cancer. In press. doi:10.1016\/j.clgc.2017.10.017.","DOI":"10.1016\/j.clgc.2017.10.017"},{"key":"10.1016\/j.eururo.2018.01.042_bib0220","first-page":"1","article-title":"Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma","author":"Beuselinck","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.eururo.2018.01.042_bib0225","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2018.01.042_bib0230","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.eururo.2012.09.037","article-title":"Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma","volume":"63","author":"Tosco","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.01.042_bib0235","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","article-title":"Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study","volume":"27","author":"Heng","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2018.01.042_bib0240","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1464-410X.2009.08490.x","article-title":"Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma","volume":"104","author":"Daliani","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.01.042_bib0245","doi-asserted-by":"crossref","unstructured":"McDermott D, Huseni M, Rini B, et al. Abstract CT081: Molecular correlates of differential response to Atezolizumab+\/-Bevacizumab vs Sunitnib in a Phase II study in untreated metastatic renal cell carcinoma (RCC) patients. Cancer Res. In press. doi:10.1158\/1538-7445.AM2017-CT081.","DOI":"10.1158\/1538-7445.AM2017-CT081"},{"key":"10.1016\/j.eururo.2018.01.042_bib0250","doi-asserted-by":"crossref","first-page":"e1042198","DOI":"10.1080\/2162402X.2015.1042198","article-title":"The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy","volume":"4","author":"De Wolf","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.eururo.2018.01.042_bib0255","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.eururo.2014.06.053","article-title":"Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkers","volume":"66","author":"Gulati","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.01.042_bib0260","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.juro.2015.02.2943","article-title":"Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy","volume":"194","author":"Thomas","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2018.01.042_bib0265","doi-asserted-by":"crossref","first-page":"176373","DOI":"10.1155\/2015\/176373","article-title":"The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy","volume":"2015","author":"Yu","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.eururo.2018.01.042_bib0270","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/cncr.25836","article-title":"Survival after complete surgical resection of multiple metastases from renal cell carcinoma","volume":"117","author":"Alt","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2018.01.042_bib0275","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.amjsurg.2010.06.029","article-title":"Evaluation of a new prognostic score (Munich score) to predict long-term survival after resection of pulmonary renal cell carcinoma metastases","volume":"202","author":"Meimarakis","year":"2011","journal-title":"Am J Surg"},{"key":"10.1016\/j.eururo.2018.01.042_bib0280","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.urology.2013.06.035","article-title":"Prognostic factors of patients with metastatic renal cell carcinoma with removed metastases: a multicenter study of 556 patients","volume":"82","author":"Naito","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2018.01.042_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1569-9056(10)60446-0","article-title":"Complete metastasectomy is an independent predictor of cancer-specific survival in patients with clinically metastatic renal cell carcinoma","volume":"9","author":"Petralia","year":"2010","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.eururo.2018.01.042_bib0290","first-page":"2","article-title":"Metastasectomy significantly prolongs survival in patients with metastatic renal cell cancer","volume":"181","author":"Staehler","year":"2009","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.eururo.2018.01.042_bib0295","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1245\/s10434-007-9782-0","article-title":"Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection?","volume":"15","author":"Zerbi","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.eururo.2018.01.042_bib0300","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000106329","article-title":"Metastasectomy without systemic therapy in metastatic renal cell carcinoma: comparison with conservative treatment","volume":"79","author":"Kwak","year":"2007","journal-title":"Urol Int"},{"key":"10.1016\/j.eururo.2018.01.042_bib0305","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1100\/tsw.2007.145","article-title":"Cytoreductive nephrectomy and nephrectomy\/complete metastasectomy for metastatic renal cancer","volume":"7","author":"Russo","year":"2007","journal-title":"Sci World J"},{"key":"10.1016\/j.eururo.2018.01.042_bib0310","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00268-007-0685-9","article-title":"Liver resection for metastases from renal cell carcinoma","volume":"31","author":"Thelen","year":"2007","journal-title":"World J Surg"},{"key":"10.1016\/j.eururo.2018.01.042_bib0315","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.eururo.2005.03.004","article-title":"Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma","volume":"48","author":"Hofmann","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.01.042_bib0320","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.juro.2008.05.006","article-title":"Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma","volume":"180","author":"Eggener","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2018.01.042_bib0325","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.athoracsur.2004.08.034","article-title":"Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma?","volume":"79","author":"Murthy","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.eururo.2018.01.042_bib0330","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1200\/JCO.1998.16.6.2261","article-title":"Resection of metastatic renal cell carcinoma","volume":"16","author":"Kavolius","year":"1998","journal-title":"J Clin Oncol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283818300976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283818300976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T12:59:45Z","timestamp":1539953985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283818300976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0302283818300976"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2018.01.042","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2018.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}